Provention prices diabetes drug above analysts’ estimates at $13,850/vial By Reuters
[ad_1] © Reuters. By Raghav Mahobe and Nandhini Srinivasan (Reuters) -Provention Bio Inc has priced its diabetes drug teplizumab at $13,850 a vial, it said...